Christine Ko
Christine Ko
Associate Professor of Dermatology and Pathology, Yale University
Verified email at yale.edu
Title
Cited by
Cited by
Year
Pediculosis
CJ Ko, DM Elston
Journal of the American Academy of Dermatology 50 (1), 1-12, 2004
2572004
Granulysin, a T cell product, kills bacteria by altering membrane permeability
WA Ernst, S Thoma-Uszynski, R Teitelbaum, C Ko, DA Hanson, ...
The Journal of Immunology 165 (12), 7102-7108, 2000
2392000
The effect of share repurchase on the value of the firm
E Elton, M Gruber
The Journal of finance 23 (1), 135-149, 1968
109*1968
Dermatopathology E-Book
D Elston, T Ferringer, CJ Ko, S Peckham, WA High, DJ DiCaudo
Elsevier Health Sciences, 2013
1042013
Dermatology essentials E-book
JL Bolognia, JV Schaffer, KO Duncan, CJ Ko
Elsevier Health Sciences, 2014
90*2014
Keratoacanthoma: facts and controversies
CJ Ko
Clinics in dermatology 28 (3), 254-261, 2010
892010
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy
KC Suozzi, M Stahl, CJ Ko, A Chiang, SN Gettinger, MD Siegel, ...
JAAD case reports 2 (3), 264-268, 2016
732016
GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation
YH Lim, A Bacchiocchi, J Qiu, R Straub, A Bruckner, L Bercovitch, ...
The American Journal of Human Genetics 99 (2), 443-450, 2016
702016
Hidradenocarcinoma: a histological and immunohistochemical study
CJ Ko, AJ Cochran, W Eng, SW Binder
Journal of cutaneous pathology 33 (11), 726-730, 2006
652006
Noninfectious granulomas
EJ Glusac
Lever's Histopathology of the skin, 373-399, 2005
602005
Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk
G Zito, I Saotome, Z Liu, EG Ferro, TY Sun, DX Nguyen, K Bilguvar, CJ Ko, ...
Nature communications 5 (1), 1-13, 2014
532014
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and …
E Coleman, C Ko, F Dai, MM Tomayko, H Kluger, JS Leventhal
Journal of the American Academy of Dermatology 80 (4), 990-997, 2019
522019
Somatic activating RAS mutations cause vascular tumors including pyogenic granuloma
YH Lim, SR Douglas, CJ Ko, RJ Antaya, JM McNiff, J Zhou
The Journal of investigative dermatology 135 (6), 1698, 2015
522015
Predicting non-melanoma skin cancer via a multi-parameterized artificial neural network
D Roffman, G Hart, M Girardi, CJ Ko, J Deng
Scientific reports 8 (1), 1-7, 2018
472018
Actinic keratosis: facts and controversies
CJ Ko
Clinics in dermatology 28 (3), 249-253, 2010
462010
Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non–small-cell lung cancer: a …
AH Kesarwala, CJ Ko, H Ning, E Xanthopoulos, KE Haglund, WP O'Meara, ...
Clinical lung cancer 16 (3), 237-244, 2015
452015
Unguioblastoma and unguioblastic fibroma–an expanded spectrum of onychomatricoma
CJ Ko, L Shi, RJ Barr, L Mölne, A Ternesten‐Bratel, JT Headington
Journal of cutaneous pathology 31 (4), 307-311, 2004
422004
Fibrillar IgA deposition in dermatitis herpetiformis–an underreported pattern with potential clinical significance
CJ Ko, OR Colegio, JE Moss, JM McNiff
Journal of cutaneous pathology 37 (4), 475-477, 2010
392010
Inverse psoriasiform eruption during pembrolizumab therapy for metastatic melanoma
MB Totonchy, HH Ezaldein, CJ Ko, JN Choi
JAMA dermatology 152 (5), 590-592, 2016
352016
Hypertrophic lupus erythematosus: the diagnostic utility of CD123 staining
CJ Ko, B Srivastava, I Braverman, RJ Antaya, JM McNiff
Journal of cutaneous pathology 38 (11), 889-892, 2011
332011
The system can't perform the operation now. Try again later.
Articles 1–20